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Aim: In this work we test the usage of dose gradient based algorithm for the selection of beam
weights in 3D-CRT plans for different cancer locations. Our algorithm is easy to implement
for three ﬁelds technique with wedges deﬁned by planner.
Background: 3D-CRT is usually realized with forward planning which is quite time consuming.
Several authors published a few methods of beams weights optimization applicable to the
3D-CRT.
Materials and methods: Optimization is based on an assumption that the best plan is achieved
if  dose gradient at ICRU point is equal to zero. Method was tested for 120 patients, treated
in  our clinic in 2011-2012, with different cancer locations. For each patient, three ﬁelds
conformal plan (6 MV and 15 MV X-ray) with the same geometry as proposed by experienced
planners was prepared. We  compared dose distributions achieved with the proposed method
and  those prepared by experienced planners. The homogeneity of dose distributions was
compared in terms of STD and near minimum and near maximum doses in the PTV.
Results: Mean difference of STD obtained by the proposed algorithm and by planners was
0.1%: 0.1% for prostate cancer, 0.3% for lung cancer, −0.1% for esophagus cancer, 0.1% for
rectum cancer, −0.1% for gynecology cancer, −0.1% for stomach cancer.
Conclusions: Applying the proposed algorithm leads to obtain the similar dose distribution
homogeneity in the PTV as these achieved by planners and therefore can serve as a supportin  creating 3D-CRT plans. It is also simple to use and can signiﬁcantly speed up the treatment
planning process.
© 2014 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.∗ Corresponding author at: Department of Medical Physics, Maria Sklod
arsaw, Poland. Tel.: +48 226449182; fax: +48 226449182.
E-mail address: m.gizynska@zfm.coi.pl (M.K. Giz˙yn´ska).
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507-1367/© 2014 Greater Poland Cancer Centre. Published by Elsevier Uowska-Curie Memorial Cancer Centre and Institute of Oncology,
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the axis. Linear ﬁtting was done with the least square method.
We have checked how the slope is changing with the depth for
depths from 6 cm to 24 cm (see Fig. 1). Mean standard deviationS10  reports of practical oncology an
1.  Background
Conformal therapy (3D-CRT) is still in common use. Simplic-
ity of beam arrangement is one of the parameters of the plan
quality. It is very important especially for palliative cases,
patients with pain or respiratory problems. That is why three
beams geometry is used very often. Usually beam weights are
chosen by trial and error process. Sherouse1 described mathe-
matical formalism of 3D-CRT radiotherapy planning based on
dose gradient analysis for open beams. He noticed that math-
ematical gradient analysis “holds promise as the basis of a
technique for automatic selection of wedge angles, collima-
tor angles, and relative beam weights as a part of a clinical
treatment design system.” Algorithm based on dose gradient
analysis applied to two and three beams therapy was proposed
by Dai.2
2.  Aim
Few authors made some effort to shorten 3D-CRT treatment
planning time. Simulated annealing,3,4 genetic algorithms,5
omni-wedge technique,6,7 and other methods8–11 were tested.
To the best of our knowledge none of these methods is in com-
mon  use. Therefore in this work we developed a method based
on dose gradient analysis. It was tested for 120 three ﬁelds
technique plans for patients with different cancer locations.
3.  Materials  and  methods
Treatment  techniques
Our method was tested for 120 plans, realized in our clinic
in 2011–2012. We  have chosen plans with six different can-
cer locations: prostate, lung, esophagus, rectum, gynecology,
stomach – 20 plans for each location. Each treatment plan con-
sists of three coplanar ﬁelds. Each ﬁeld was set to 6 MV  or
15 MV  X-ray depending on a tumor depth. The shape of the
ﬁelds was obtained with multileaf collimator. We calculated
ﬁeld weights with our algorithm for the same geometry as
prepared by experienced planner.
3.1.  Optimization  of  beam  weights
According to Sherouse we  assumed that the most homoge-
neous dose distribution in the PTV is obtained if dose gradient
at ICRU point is zero. In order to ﬁnd ﬁeld weights we had to
solve following set of equations:
⎧⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎩
3∑
i=1
wi · Di(ICRU) = Dp(ICRU)
3∑
i=1
wi · ∇Di(ICRU) = 0
(1)where wi are beam weights. In our model beam normaliza-
tion is calculated with formulae: (PDD(d)/PDD(ICRU)) · (Dp/n),
where n = 3 and d is depth of the ICRU Reference Point for thediotherapy 1 9 ( 2 0 1 4 ) S9–S12
n beam. This means that weights are proportional to the dose
delivered from each single beam to ICRU point. We decided to
use isocenter, chosen by planner, as an ICRU point. The ﬁrst
equation of formulae (1) guarantees that the dose at ICRU point
would be equal to prescribed dose Dp. Second equation sets the
dose gradient at ICRU point to zero. This set of equations has
exactly one solution. We had considered two possible ways of
calculating PDD(d). One way was to look into the tables and
measurement and second (easier one) was to use formulae
described by Gerbi12:
PDDSDD(d) = 10[p1+p2·d+(p3+p4 ·d) log(A/P)] (2)
In Eq. (2) pi are factors which depend on beam quality
index (TPR20/10), d stands for depth, A and P are ﬁeld area and
periphery, respectively. PDD was recalculated from one SSD to
another with the formulae:
PDD2(d, As, SSD2) = PDD1(d, AS, SSD1)
TAR(d, Ad2 )
TAR(d, Ad1 )
·
(
SSD2 + dmax
SSD2 + d
)2
·
(
SSD1 + dmax
SSD1 + d
)−2
(3)
The factor TAR(d, Ad2 )/TAR(d, Ad1 ) is very close to 1, and
therefore was neglected.
Dose gradient component (∇Di) parallel to central axis has
to be calculated, at particular depth, from depth dose curve.
Dose gradient component perpendicular to central axis has
to be calculated from the dose proﬁle (in the transversal axis
direction) at depends mostly on wedge angle. Finally the dose
gradient is a vector sum of these two gradients.
In order to calculate dose gradient component transversal
to beam axis we ﬁt line to the dose proﬁle for wedged beams in
the surrounding of the central axis in the distance ±1 cm fromFig. 1 – Comparison of slope value for different depths and
different wedges.
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f slope for different depths was equal 3% of the mean slope
alue.
To calculate beam weights the following parameters were
ntroduced: depth of ICRU point along the central beam axis,
eld size, wedge angle (represented by the slope of central part
f proﬁle), depth of maximum dose (dmax) and beam quality
ndex (TPR20/10).
.2.  Implementation  of  a  model  for  cancer  patients
fter calculating beam weights and wedge angles, which was
one by solving the set of Eq. (1) in an analytic way with
 help of computer program, they were introduced into TPS
Eclipse v.8.9: Varian Medical Systems, Palo Alto, CA with
nisotropic Analytical Algorithm 10.0.28). We compared sta-
istical parameters of dose distribution achieved with beam
eights optimization method and by experienced planners.
e compared dose distribution homogeneity in terms of: dose
tandard deviation (STD), near minimum and near maximum
ose in target volume. In our opinion D98% and D2% serve bet-
er as an estimation of dose distribution than Dmin and Dmax
hich are point doses.
.3.  Calculations
ll calculations were carried out with homemade program
repared in the free Python language.13
.  Results
ean difference of STD obtained by the proposed algorithm
nd by planners (with trial-and-error forward planning pro-
ess) was 0.1% (see Fig. 2 for details).
For prostate cancer 1 plan prepared with algorithm had
maller STD than that prepared by planner (−0.25% of pre-
cribed dose), for 7 plans no difference was observed, for other
Fig. 2 – Histogram of dose standard deviation difference betwtherapy 1 9 ( 2 0 1 4 ) S9–S12 S11
plans STD in plan prepared with algorithm was higher (up to
1.5% of prescribed dose). Mean D98% difference was −0.2%
(range −2.1% to 0.4%) and mean D2% was 0.3% (range −0.8%
to 2.8%).
For lung cancer 2 plans prepared with algorithm had
smaller STD than that prepared by planner (up to −0.5% of
prescribed dose), for 4 plans no difference was observed, for
other plans STD in plan prepared with algorithm was higher
(up to 1.75% of prescribed dose). Mean D98% difference was
−0.4% (range −2.8% to 0.7%) and mean D2% was 0.9% (range
−1.2% to 3.3%).
For esophagus cancer 5 plans prepared with algorithm had
smaller STD than that prepared by planner (up to −0.75% of
prescribed dose), for 7 plans no difference was observed, for
other plans STD in plan prepared with algorithm was higher
(up to 0.5% of prescribed dose). Mean D98% difference was
0.2% (range −1.7% to 1.6%) and mean D2% was −0.1% (range
−1.8% to 1.6%).
For rectum cancer 1 plan prepared with algorithm had
smaller STD than that prepared by planner (−0.5% of pre-
scribed dose), for 8 plans no difference was observed, for other
plans STD in plan prepared with algorithm was higher (up
to 1% of prescribed dose). Mean D98% difference was −0.1%
(range −1.1% to 0.4%) and mean D2% was 0.3% (range −1.2%
to 1.9%).
For gynecology cancer 4 plans prepared with algorithm had
smaller STD than that prepared by planner (−0.75% of pre-
scribed dose), for 7 plans no difference was observed, for other
plans STD in plan prepared with algorithm was higher (up
to 0.5% of prescribed dose). Mean D98% difference was 0.1%
(range −0.9% to 1.3%) and mean D2% was 0.3% (range −1.6%
to 1.8%).
For stomach cancer 7 plans prepared with algorithm had
smaller STD than that prepared by planner (up to −1% of pre-
scribed dose), for 3 plans no difference was observed, for other
plans STD in plan prepared with algorithm was higher (up
een plans prepared by planners and with our algorithm.
d ra
r
1
1
1S12  reports of practical oncology an
to 1% of prescribed dose). Mean D98% difference was 0.2%
(range −1.1% to 1.6%) and mean D2% was 0.2% (range −1.8% to
3.0%).
5.  Discussion
STD differences which have been obtained in most plans
should not lead to signiﬁcant change in TCP 14. For more  than
50 patients STD was equal or even better for our algorithm.
Possible reason for higher STD for plans prepared with algo-
rithm can be patient body shape. Dai and Zhu6 also noticed
a problem in accounting a patient’s body shape and tissue
inhomogeneity. In our previous work we proposed the solu-
tion of this problem. We  identiﬁed inﬂuence of patients body
shape on open beams proﬁles as an additional wedge. We
showed that introducing these proﬁles into our set of Eqs. (1)
is sufﬁcient enough.
In forward 3D-CRT planning the planner must choose
the appropriate ﬁelds geometry, beam energy, wedges, beam
weights and of course number of beams. The most important
are the number of beams and their positions (for isocentric
techniques angles of beams) with respect to target volume
and sensitive structures. Several parameters of beams may be
deﬁned automatically, the isocenter, the shape of each sin-
gle beam. The simplicity of a plan, especially in palliative
treatment has an important role. Therefore quite often two
opposed beams are used. Our method allows a more  compli-
cated geometry for easy planning, e.g. three ﬁelds technique.
The method ensures that dose distribution in the target vol-
ume  is quite homogenous.
6.  Conclusion
Nowadays the main effort in TPS development is directed on
searching optimization methods for IMRT  and VMAT tech-
niques. One cannot forget that 3D-CRT would be used in
clinical practice as well, also because we do 3D-CRT plans
for many  palliative cases, what was not done before. In most
countries more  than 40% of patients have palliative treatment.
Therefore using 3D-CRT instead of standard 2D treatment is
time-restricted. Our work shows that it is possible to create
very easy and effective methods of dose distribution optimiza-
tion for 3D-CRT plans.
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